S-Network Medical Breakthroughs Index

An index of small and mid-cap biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials.

As January 25, 2023 Index Level 3-Month 6-Month 1-Year YTD
Price Return 7,282.2 8.0% 8.5% -3.8% 6.4%
Total Return 7,743.8 8.0% 8.5% -3.8% 6.4%
Net Total Return 7,728.1 8.0% 8.5% -3.8% 6.4%
Index Level 7,282.2
3-Month 8.0%
6-Month 8.5%
1-Year -3.8%
YTD 6.4%
Index Level 7,743.8
3-Month 8.0%
6-Month 8.5%
1-Year -3.8%
YTD 6.4%
Index Level 7,728.1
3-Month 8.0%
6-Month 8.5%
1-Year -3.8%
YTD 6.4%

As of January 25, 2023

Characteristics

Index Symbol (Price Return) PMBI
Index Symbol (Total Return) PMBITR
Index Symbol (Net Total Return) PMBINT
Number of Constituents 116
Market Capitalization $174 Billion
Adjusted Market Capitalization $110 Million
Rebalancings Quarterly
Dividend Yield 0.0%

Composition

Top Index Constituents
As of February 5, 2023

Interested in Market Data packages?

VettaFi's indexes are widely used by financial firms, industry stakeholders and professionals to support a variety of business functions. We offers a range of end-of-day and historical index data subscriptions.

Contact Us